Clinical Virology

Medicine & Life Sciences

1. Alternative Complement Pathway 9%
2. Animal Diseases 8%
3. Animal Models 11%
4. Antibodies 6%
5. Antiviral Agents 35%
6. Apolipoproteins E 7%
7. Belgium 9%
8. Capsid 7%
9. Carboxypeptidase B2 10%
10. CD36 Antigens 12%
11. Chronic Hepatitis C 5%
12. Classical Complement Pathway 9%
13. Claudin-1 9%
14. Coronavirus 8%
15. Coronavirus Infections 9%
16. Developed Countries 6%
17. Dipeptidyl Peptidase 4 9%
18. Edetic Acid 5%
19. fibroblast activation protein alpha 11%
20. Flunarizine 9%
21. Genotype 9%
22. Hemolysis 6%
23. Hepacivirus 100%
24. Hepatitis C 8%
25. Hepatitis C Antibodies 12%
26. Hepatitis E virus 9%
27. Hepatocytes 19%
28. Histones 6%
29. HIV 10%
30. In Vitro Techniques 11%
31. Infection 12%
32. Influenzavirus C 11%
33. interferon type III 5%
34. Interferons 5%
35. Interleukins 7%
36. Life Cycle Stages 11%
37. Lipoproteins 10%
38. Liver 17%
39. Liver Diseases 10%
40. Liver Transplantation 10%
41. lysosomal Pro-X carboxypeptidase 12%
42. Monkeypox virus 11%
43. Monoclonal Antibodies 18%
44. Monocytes 5%
45. Natural Killer Cells 6%
46. Neutralizing Antibodies 8%
47. Peptide Hydrolases 11%
48. Proline 7%
49. prolyl oligopeptidase 10%
50. Ribavirin 5%
51. RNA Interference 6%
52. Secondary Prevention 6%
53. Severe Acute Respiratory Syndrome 8%
54. Sexual Health 7%
55. Syphilis 7%
56. Therapeutics 7%
57. Tight Junction Proteins 6%
58. Transplants 6%
59. Tyrosine 7%
60. Virion 15%
61. Virus Diseases 32%
62. Virus Internalization 10%
63. Virus Receptors 5%
64. Virus-Like Particle Vaccines 10%
65. Viruses 12%